EMEA-001452-PIP01-13-M03

Key facts

Active substance
daprodustat
Therapeutic area
  • Haematology-Hemostaseology
  • Uro-nephrology
Decision number
P/0047/2021
PIP number
EMEA-001452-PIP01-13-M03
Pharmaceutical form(s)
  • Dispersible tablet
  • Tablet
Condition(s) / indication(s)
Treatment of anaemia due to chronic disorders
Route(s) of administration
Oral use
Contact for public enquiries
GlaxoSmithKline Trading Services Limited

Tel. +1 4388998201
E-mail: eu.paediatric-plans@gsk.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating